Sign In
Buy PALI
$1.93
+0.0700 (+3.76%)
At Close: Jun 03, 2026
Palisade Bio Provides Corporate Update and Reiterates Guidance
08:35am, Tuesday, 13'th Feb 2024
– Company announces strategic streamlining of Board to align with the current state of clinical development and corporate vision
Correction Notice of Palisade Bio's Press Release Announcing the Appointment of Clinical Advisory Board Members
02:40pm, Thursday, 08'th Feb 2024
Carlsbad, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for se
Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders
08:05am, Thursday, 08'th Feb 2024
Carlsbad, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for ser
Why Is Palisade Bio (PALI) Stock Up 100% Today?
02:01pm, Monday, 29'th Jan 2024
Biopharmaceutical company Palisade Bio (NASDAQ: PALI ) is seeing its market value skyrocket off multiple encouraging catalysts today. While PALI stock still remains an extremely risky proposition, inv
Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn's & Colitis Congress
08:05am, Monday, 29'th Jan 2024
– Preclinical data demonstrated PALI-2108 to be safe and well tolerated – PALI-2108 is orally delivered and colon activated allowing for local activity with low systemic exposure – Company advan
Palisade Bio Announces Receipt of Second Milestone Payment from the US Crohn's and Colitis Foundation for Development of PALI-2108
08:00am, Thursday, 28'th Dec 2023
- Company's co-development partner, Giiant Pharma, Inc. (“Giiant”), receives funding as part of previously announced grant from the US Crohn's and Colitis Foundation
Why Is Palisade Bio (PALI) Stock Down 46% Today?
10:28am, Thursday, 07'th Sep 2023
Palisade Bio (NASDAQ: PALI ) stock is falling on Thursday after the clinical-stage biopharmaceutical company announced a share offering. Palisade Bio is selling 2,339,398 shares of PALI stock through
Palisade (PALI) In-Licenses Rights for IBD Candidate, Stock Up
09:01am, Thursday, 07'th Sep 2023
Palisade (PALI) gains on entering into global licensing deal with Giiant Pharma to develop gastrointestinal therapies.
Palisade Bio's stock more than doubles on news of licensing deal with Giiant Pharma for IBD therapies
10:11am, Wednesday, 06'th Sep 2023
Palisade Bio Inc.'s stock PALI more than doubled in price on Wednesday, after the company announced a licensing agreement with privately held Giiant Pharma Inc. Carlsbad, Calif.-based Palisade said th
Palisade Bio Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
08:45am, Wednesday, 14'th Jun 2023
Live webcast fireside chat on Thursday, June 22 nd at 11:30 AM ET
Palisade Bio, Inc. (PALI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
11:08am, Tuesday, 23'rd May 2023
Palisade Bio, Inc. (PALI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could
Palisade (PALI) Enrolls First Patient in LB1148 Study in China
03:14pm, Thursday, 06'th Apr 2023
Palisade's (PALI) development partner, Newsoara, enrolls first patient in the late-stage clinical study of LB1148 to improve postoperative GI function for patients in China.
Why Is Palisade Bio (PALI) Stock Up 36% Today?
08:06am, Friday, 31'st Mar 2023
Palisade Bio (NASDAQ: PALI ) stock is on the rise Friday after the biopharmaceutical company got an upgrade from an analyst. Maxim Group is behind today's upgrade for PALI stock.
What Makes Palisade Bio, Inc. (PALI) a New Buy Stock
01:46pm, Wednesday, 29'th Mar 2023
Palisade Bio, Inc. (PALI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Palisade Bio to Present at the Virtual Investor 2023 Companies to Watch Event
08:45am, Monday, 09'th Jan 2023
Live video webcast on Tuesday, January 17 th at 3:00 PM ET
